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Using patient-level data from 35 hospitals for 6 cardiovascular surgeries in New York, we provide empirical
evidence that outcome differences between health care providers are heterogeneous across different groups
of patients. We then use a causal tree approach to identify patient groups that exhibit significant differences
in outcome. By quantifying these differences, we demonstrate that a large majority of patients can achieve
better expected outcomes by selecting providers based on patient-centric outcome information. We also show
how patient-centric outcome information can help providers to improve their processes and payers to design
effective pay-for-performance programs.
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1. Introduction
Choosing a health care provider for a major medical procedure can be literally a life or death
decision. However, because they have historically lacked clear quality information about providers,
most patients have made these important choices based on proximity or familiarity.1 Even patients
who have relied on physician referrals have been unable to rigorously evaluate their options, because
the physicians themselves have lacked objective data and therefore have had to rely on subjective
reputation information.
Recognizing the critical need among patients for more and better information about health
care providers, government and private organizations have made various efforts to provide patient-
oriented hospital ratings. For example, the Center for Medicare & Medicaid Services (CMS) main-
tains the Hospital Compare web site to compare Medicare-certified hospitals across the country
and the US News provides aggregate hospital ratings for broad categories of procedures such as
1 http://www.infographicsarchive.com/health-and-safety/2014-healthgrades-american-hospital-quality-report-
nation/
1
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heart surgery and cancer. These, and other rating systems like them, compare hospitals based on
risk-adjusted rates of mortality, complication and/or readmission, and assign scores or star ratings
to hospitals based on their outcome measures.
However, a widely overlooked reality is that these ratings are based on population averages
(hereinafter referred to as “population-average information”), which imply that the same hospitals
are best for all patients. But this is an assumption built into population-average based ratings,
rather than an empirical fact. To illustrate how such ratings can be misleading, consider a simple
example of three hospitals and two procedure types — Coronary Artery Bypass Grafting (CABG)
and Mitral Valve Surgery. The mortality rates of these three hospitals are 1%, 4% and 2% for
CABG patients, and 5%, 2% and 3% for mitral patients. If all three hospitals have a 50/50 mix
of CABG and mitral patients, the overall mortality rates are 3%, 3% and 2.5%, respectively. If
hospitals are ranked according to overall mortality rate, then the third hospital will come out on
top, even though it is not the best for either procedure type. Hence a population average ranking
on overall mortality rate will misguide patients (and their primary care physicians) in the choice
of a hospital. By suggesting the same hospital for everyone, it will also contribute to a capacity
imbalance.
In recognition that a hospital may perform well for some procedures and not as well for other
procedures, some states such as New York and Pennsylvania have begun publishing hospital quality
report cards for individual cardiac surgeries such as coronary artery bypass grafting, aortic valve
and mitral valve surgeries. But this still does not provide true patient-centric information, because
patients requiring the same procedure differ in their demographics and severity of illness (Huckman
and Kelly, 2013). Hospital outcomes may be sensitive to these differences and the best hospital may
be different for different patients.2 In this paper, we focus on how to measure the heterogeneity of
patient outcomes using readily available data, and how to use the results to generate patient-centric
hospital ratings.
Patient-centric ratings have obvious use in helping individual patients choose a hospital. But
they have other important uses as well. The US government is devoting considerable energy to
designing payment structures that incentivize hospitals to improve quality. Most prominently,
CMS has developed programs to link Medicare payments to hospital performance. For example, it
2 For example, diabetic patients in need of coronary bypass surgery have generally not been treated using the Bilateral
Internal Thoracic Artery (BITA) grafting technique, because of concerns that they are at higher risk of infection
involving the breast bone. However, the Cleveland Clinic found recently that BITA grafting can work very well for
diabetic patients, except for those that are very overweight with diffuse atherosclerosis or widespread hardening of
the arteries (see https://health.clevelandclinic.org/2014/11/the-best-bypass-surgery-option-for-diabetic-patients/ for
more details). Similarly, surgeons at the Greenville Health System have found that patients with end stage renal
disease (ESRD) require special care because they are at a higher risk for complications and death after surgical
procedures including bypass grafting (Schneider et al., 2009).
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launched the Readmission Reduction Program (RRP) in 2013 to penalize hospitals with excessive
30 day readmission rates and the Hospital Acquired Conditions Reduction Program (HACRP) in
2015 to penalize low performers with regard to hospital acquired infections.3 In both programs, if
a hospital’s performance is below a threshold, the hospital is penalized for all its Diagnosis-Related
Groups (DRGs). In 2015, more than 2,000 hospitals were penalized under RRP and more than 700
hospitals were penalized under HACRP.
A problem with both RRP and HACRP is that they rely on population average data. As a
result, they penalize some hospitals for all their procedures and do not penalize other hospitals for
any procedure. As we noted above, low average performance does not necessarily mean that the
hospital is poor at treating all patients. It is possible that some of the penalized hospitals have
good or even excellent performance for some patients. Likewise, hospitals that are not penalized
at all may be providing poor performance to some patients. The result is a misalignment between
the penalties (or lack of them) and hospital performance, and hence misalignment in the incentives
to improve. Using patient-centric ratings allows payers such as CMS to assess hospital quality by
patient group and thereby direct penalties more accurately at areas of poor performance.
In this paper, we examine six cardiovascular surgeries at thirty-five NY hospitals and address
four key questions: (1) Are the outcome differences between hospitals heterogenous across different
patient groups? (2) How can we identify groups of patients that exhibit significant differences in
outcome? (3) How can we quantify the differences in patient outcomes between hospitals in a
(patient-centric) manner that is useful to individual patients? and (4) What are the benefits of
patient-centric ratings to patients, payers and providers?
To answer the first question, we can partition patients into different groups according to their
medical condition/procedure, as well as various patient characteristics such as age and comorbidi-
ties. For each group, we compare the outcomes of different hospitals and estimate the outcome
differences between hospitals.
As mentioned earlier, various consumer-based hospital rating systems such as the New York
State Cardiac Surgery Reporting System attempt to do this by comparing hospitals across differ-
ent procedures. Table 1 summarizes the risk-adjusted mortality rates and the relative ranking of
six hospitals for three cardiovascular surgeries based on New York Cardiovascular Surgery Quality
Report Cards 2011-2013.4 The results show clearly that outcome differences are indeed heteroge-
nous across procedures. To see whether outcome differences are also heterogenous across other
dimensions of patient characteristics, we need a way to group patients to generate patient-centric
outcomes. This presents us with the second question.
3 https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/index.html
4 https://www.health.ny.gov/statistics/diseases/cardiovascular/
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The standard approach for partitioning patients into groups would be to include interaction
terms between hospital indicators and patient groups as covariates in a multivariate regression
model. This method works well when there is a small number of groups, but quickly breaks down
when, as is the case here, the number of patient characteristics is large. Methods such as LASSO can
reduce the dimensionality of the problem, but rely on assumptions of sparsity and linear additivity,
and impose distributions on the error term.
Table 1 Relative Performance of Hospitals for Different Procedures
Procedures
Lenox Hill
Hospital
Mount
Sinai
NYP-
Columbia
NYP-Weill
Cornell
Rochester
General
St. Francis
Hospital
Coronary Count 256 385 419 176 306 658
Artery Bypass Mortality 2.23% 1.80% 1.10% 1.74% 1.65% 1.54%
Grafting Rank 6 5 1 4 3 2
Valve- Count 479 1820 2228 1303 1025 1831
Related Mortality 3.30% 3.10% 2.88% 2.63% 4.91% 3.28%
Surgeries Rank 5 3 2 1 6 4
Percutaneous Count 1551 4522 2541 1298 1569 2289
Coronary Mortality 0.59% 0.92% 1.05% 1.50% 0.99% 0.82%
Intervention Rank 1 3 5 6 4 2
Source: New York Cardiovascular Surgery Quality Report Cards 2011-2013.
These issues can be addressed by a nonparametric method that partitions patients into groups
such that patients within the same group have similar outcome differences between providers.
Unfortunately, while simple to state, it is not straightforward to find the best way to group patients.
First, there are many patient characteristics to consider, so we need to identify those that affect
provider outcome differences. Second, for a given set of patient characteristics, there are many
different ways to group patients. To see this, consider a simple example with patients of two
genders {male, female} and two races {white, black}. These can be grouped into {male, white},
{male, black}, {female, white} and {female, black}. Since the number of patient groups increases
exponentially with the number of patient characteristics, real world settings will have too many
groups to evaluate each one individually with statistically significant results.
In this study, we use tree-based methods from the machine learning literature to recursively par-
tition patients into smaller groups such that patients within each group have similar characteristics.
We compare the traditional regression tree method with the recently proposed causal tree method
and explain why the causal tree method is better able to find heterogenous outcome differences
between providers. However, we also note that the causal tree method was originally developed
to identify binary treatment effects. To extend this approach to identify heterogeneous provider
effects when there are multiple providers, we have to overcome two challenges. First, in addition
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to grouping patients, we also need to group providers because there may not be sufficient data to
detect significant differences between all pairs of providers. Second, we need to derive from our
groupings easy-to-understand outcome information for use by individual patients. Accomplishing
the latter addresses the third key question of deriving patient-centric information by comparing
outcomes of different providers.
To address the fourth key question of how patient-centric information can be used to improve
patient outcomes, we compare scenarios in which patients use patient-centric and population-
average information to select the best provider for them. This characterizes the magnitude of
benefit to individual patients of having patient-centric, instead of population-average, data. We
also illustrate the potential impact of patient-centric information on hospitals and payers to show
how hospitals can use such information to target quality improvements and how Medicare can use
it to better align payments with hospital performance.
2. Literature Review
There is growing interest in hospital quality from both the medical and operations management
communities. The medical literature has focused primarily on identifying hospital characteristics
that indicate better performance. For example, Keeler et al. (1992) compared 197 hospitals and
found that teaching, large and urban hospitals are generally better than non-teaching, small, and
rural hospitals for congestive heart failure, acute myocardial infraction, pneumonia, stroke or hip
replacement. Birkmeyer et al. (2003), Gammie et al. (2009) and Vassileva et al. (2012) found high-
volume hospitals tend to perform better than low-volume hospitals. Tsai et al. (2015) found that
hospitals with boards that pay greater attention to clinical quality and use clinical quality metrics
have more effective management practices and provide higher-quality care.
The operation management literature has taken a more detailed perspective by focusing on the
impact of specific provider practices on performance. For example, Barro, Huckman and Kessler
(2006), Clark and Huckman (2012), Huckman and Zinner (2008), and KC and Terwisch (2011)
analyzed the impact of hospital specialization/focus on productivity and patient outcome; Clark,
Huckman and Staats (2013), Huckman and Pisano (2006), KC and Staats (2012), KC et al. (2013)
and Ramdas et al. (2014) analyzed the impact of related experiences on surgeon performance;
Freeman et al. (2015), Jaeker and Tucker (2015) and Kim et al. (2015) analyzed the impact of
workload on quality and patient outcome; Bavafa et al. (2013), Lu and Lu (2016), and Song et
al. (2015) analyzed the impact of patient-physician communication, mandatory overtime laws and
queue management on productivity and patient outcome.
A common assumption in both literatures is that the effects of quality driver are homogeneous
across patient groups. Any study that gives a single ranking of providers or a single estimate of the
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impact of a practice on quality, regardless of patient group, is implicitly making this assumption.
But a number of scholars have recognized the potential for this assumption to lead to inaccurate
information to patients and have called for heterogeneous effect analysis in both patient care and
quality assessment (see for example, FDA, 2013, Gerteis, 1993, IOM, 2011, Kattan and Vickers,
2004, Kent and Hayward, 2007, Kravitz et al., 2004). Wang et al. (2016) compared medical out-
comes of mitral valve patients treated by surgeons at different hospitals and found heterogeous
outcome differences across different patient groups.
Existing models that incorporate heterogeneity usually assume latent classes of consumers with
different tastes or that consumer tastes are random draws from a known distribution. For example,
Xu et al. (2016) used a random coefficient multinomial logit model to characterize heterogeneous
patient preferences in choose doctors. Guajardo, Cohen and Netessine (2016) also used a random
coefficient multinomial logit model to study the impact of service attributes on consumer demand in
the US automobile industry. Lu et al. (2013) used a similar model to analyze how waiting in queue in
the context of a retail store affects customers’ purchasing behavior. While such modeling framework
is useful in incorporating heterogeneous consumer preferences, they cannot systematically identify
different combinations of characteristics that define heterogeneous consumer groups. As a result,
it offers litter practical guidance to individual consumers.
The machine learning literature, on the other hand, offers several useful frameworks to measure
heterogeneity and to identify heterogeneous groups. For example, a few studies have proposed
methods to analyze the heterogeneous treatment effects. Evaluating patient differences in the effect
of a single treatment (e.g., a clinical trial of a new drug) is similar, although not identical, to
evaluating patient differences in the relative outcomes across a set of providers. Hence, we discuss
the literature on identifying heterogenous treatment effects as a guide to addressing heterogenous
provider effects.
In two separate studies of biological markers in high-dimensional genomic data, Signovitch (2007)
and Tian et al. (2014) applied the standard LASSO procedure with modified outcomes or covariates
to determine from a large set of biological markers the subset of patients that can potentially
benefit from a treatment. Imai and Ratkovic (2013) modified the standard LASSO procedure
using different penalty factors for the covariates and treatment effects to distinguish the effect of
treatment from that of covariates and to allow for the possibility of treatment effects with small
magnitudes. Since they do not systematically partition patients into groups, these methods require
users to define patient groups a priori. All of them apply a single global model to all observations,
and assume that effects are linearly additive and errors follow some distribution.
Realizing that a single global model can not be applied to all observations, Zeileis, Hothorn and
Hornik (2008) proposed to partition the observations into groups and apply separate local models
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such as linear regression or maximum-likelihood based models to individual groups. They proposed
using a tree-based method to partition observations, where the feature with the highest instability
is used to split groups, with a fluctuation test to analyze the parameter stability at a node. Su et
al. (2009) modified the regression tree method to split the predictor space in a way that maximizes
the square of the t-statistic for testing the null hypothesis that the average treatment effect is the
same in the two potential groups. A tuning parameter is used to penalize complex trees with many
terminal nodes, where the value of the parameter is determined through cross-validation based on
the sum of squares of the split t-statistics. These methods split the predictor space based on model
fit or a test-statistic, and do not use cross-validation to select the tuning parameter or to assess
the goodness of fit of the estimated model. Furthermore, by their design these methods are better
suited to outcome prediction than to heterogenous treatment effect analysis.
Recently, Athey and Imbens (2016) proposed a causal tree method to analyze heterogeneous
treatment effects in studies with binary treatments. This method effectively partitions subjects
into groups with either large or small treatment effects. The same concept can be applied to
analyze the heterogenous provider effect when there are two providers by interpreting one hospital
as “treatment” and the other hospital as “control”. However, the causal tree method cannot be
used directly when there are multiple providers, because it is unclear which provider or providers
should be designated as the treatment or control groups. Moreover, while the causal tree method
can be applied to each pair of providers, presenting such pairwise comparisons directly to patients
is likely to be confusing since there may be hundreds of comparisons for a patient to process to
come to a conclusion. In this study, we address all these issues in order to derive easy-to-understand
patient-centric information on a set of providers.
We are not the first to apply machine learning techniques to the field of operations management.
Exiting studies have developed and applied machine learning techniques for better prediction or
decision-making. For example, Ang et al. (2015) developed a new method that combines queueing
theory and the LASSO procedure to improve the prediction of emergency department waiting time.
Bertsimas et al. (2016) used several machine learning methods (LASSO, random forest and support
vector machines) to predict the outcomes of clinical trials and optimize the test regimes. Bastani
and Bayati (2016) developed a new efficient multi-armed bandit algorithm based on the LASSO
estimator to tailor decision-making at individual levels. They illustrated that superior performance
of this algorithm in warfarin dosing. Ban et al. (2016) introduced performance-based regulariza-
tion to improve portfolio performance. Ferreira et al. (2015) used a regression tree approach to
predict demand and to optimized price, which led to 9.7% revenue increase in a field experiment
implemented at an online retailer.
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3. The Model
In this section, we first describe the needs and the challenges of generating patient-centric outcome
information. We then introduce the regression tree and causal tree methods from the machine
learning literature and discuss how to extend them to identify heterogeneous outcome differences
between providers across patient groups.
3.1. Problem Description
The basic problem in which we are interested is identifying the provider, or set of providers, with
the highest likelihood of providing a good outcome for a given patient. The data to us are the
outcomes of prior patients at the various providers. However, because it is possible that outcomes
are influenced by patient characteristics (e.g., age, comorbidities, etc.), prior patient outcomes
are not equally relevant to the given patient. Patients with characteristics that match those of
the given patient are more likely to be representative, than are patients with radically different
characteristics. For instance, a 48-year old black woman with mitral valve disease and hypertension
will probably get better information from outcomes of other middle aged mitral valve patients than
she would from patients in their 90s with coronary artery disease.
While this insight is intuitive, it raises the important question of how similar a patient must be
to provide useful information about likely outcomes. For example, are gender or race important?
Or could the black female patient use outcomes from white male patients to help evaluate her
options? Are only mitral valve patients relevant, or are patients with aortic valve disease also
representative? Does hypertension matter? Or are outcomes from patients with other comorbidities,
or no comorbidities, good indicators for our patient with hypertension? How much does age matter?
Should our patient look only to outcomes for other 48 year olds, or should she consider patients
within some wider window of ages? And so on. Ideally, a method for generating outcome information
for a specific patient should also identify the cohort of patients from which this information should
come.
The basic tradeoff involved in selecting a cohort is one of precision versus power. A very narrow
cohort that closely matches the patient in question along all dimensions will be highly representative
and hence precise in characterizing outcomes, but may be too small to offer statistical power needed
to detect real and important differences between providers. A very broad cohort, which contains
patients that may not resemble the patient in question, will be less precise in estimating outcomes
but will have more power due to the larger sample size. The balance between precision and power
should be struck endogenously by making use of the data itself.
Finally, a key characteristic of our problem is that we are seeking to characterize differences
between provider outcomes. In contrast, most analyses focus on outcome prediction. The latter
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is relevant if a patient is choosing whether or not to receive a procedure. For example, to decide
whether the risk of heart surgery is justified by the benefits, we need an estimate of the mortality
rate from the procedure. However, once we have decided to receive a procedure and must decide
on a provider, it is the difference in the mortality rates between the candidate providers that
matters. In a deterministic world, where we know the absolute mortality rates, we can compute the
differences via simple subtraction. But in a statistical world, where we can only estimate the rates,
a method that focuses on prediction of the absolute rates may not yield the most accurate estimate
of the differences between rates. We focus explicitly on estimating differences between providers,
in the following discussion of regression and causal trees, and in the subsequent empirical analysis.
3.2. Regression Trees
The regression tree method partitions observations into smaller groups such that the outcomes
within each group are similar to each other. A typical algorithm starts at the top of the tree, which
consists of a single group called “parent group”, and successively makes binary splits of groups
based on the most important predictor. The process is repeated until a stopping criterion is met
(for example, the incremental improvement in prediction accuracy or the number of observations in
a group reaches a specified minimal level). The terminal nodes of a tree represent the final groups
of observations that are expected to have similar outcomes.
Obviously, there is a tradeoff between prediction accuracy and tree complexity (number of ter-
minal nodes). It is easy to see that a complex tree (e.g., each observation has its own group) will
closely represent the data used to create the tree. Therefore, regression trees are generally evalu-
ated according to their ability to predict a separate out-of-sample set of data. A complex tree will
produce highly accurate in-sample predictions but may lead to poor out-of-sample predictions due
to over-fitting. To formulate the process for creating a regression tree, we let N train denote the
number of observations in the training sample. We let M denote the number of terminal nodes,
which are exhaustive and non-lapping. Finally, we let L= {l1, .., lM} denote the M terminal nodes,
and Yi denote the observed outcome of patient i. A regression tree solves
min 1
Ntrain
[
∑M
j=1
∑
i∈lj (Yi− Y¯lj )2] +αM
s.t. L= {l1, ..., lM};
li ∩ lj = ∅,∀i 6= j.
where Y¯lj is the average outcome of the jth terminal node, and α is the tuning parameter which
penalizes complex trees. Given any α, one can solve the above optimization problem to minimize in-
sample prediction error. One can also vary the value of α to minimize the out-of-sample prediction
error over a number of cross-validation test samples: 1
Ntest
∑
i=1(Y
test
i − Yˆ testi )2, where Y testi and
Yˆ testi denote the true and predicted outcomes for patient i in the test samples.
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The regression tree method is well-suited to estimation of absolute outcomes because it identifies
important predictors of outcomes and partitions observations into groups with similar characteris-
tics. However, a regression tree designed to achieve the best average out-of-sample predictions may
not accurately characterize the relative differences between providers for different patient groups.
There are two potential approaches to modify the regression tree method to better serve our
goal of providing patient-centric information for comparing providers. One approach is to include
providers as predictors in the regression tree. If the tree does not split on any of the providers in a
group, it means that all of the providers in that group have the same outcome. However, a short-
coming of this approach is that, if one or more patient characteristics (e.g., age or comorbidities)
has a strong effect on outcomes, the tree will split first on these patient characteristics, leading to
smaller groups in successive stages. Small samples may prevent the tree from splitting further even
if outcomes differ between providers. For example, consider a simple case where Provider 1 is better
than Provider 2 at treating male patients and equally good at treating young or old patients. The
preferred tree should split only on gender. However, if age affects outcome more than gender does,
the regression tree will split first on age and may not split further on gender.
The second approach is to fit two separate trees for the two providers using only patient char-
acteristics as predictors. For a patient with given characteristics, we can calculate the outcome
difference between providers using average outcomes of the corresponding terminal nodes to which
the patient belongs. However, if a provider is too small, the regression tree will not split on any
predictors, leading to a single terminal node that consists of all patients treated by that provider.
Such an outcome may obscure patient characteristics that matter to outcomes. Furthermore, even
when the trees split, the predictors that affect treatment outcomes may be different from those
affect outcome differences. Hence, this approach may not yield appropriate patient-centric provider
comparisons.
3.3. Causal Tree
Athey and Imben (2016) proposed a causal tree framework to analyze heterogenous treatment
effects. Below, we first describe how an analogous approach can be used to identify heterogeneous
provider effects when there are two providers, and then extend it to identify heterogenous provider
effects when there are multiple providers.
3.3.1. Casual Tree with Two Providers The main difference between a causal tree and a
regression tree is the objective function used to define splitting criterion. Recall that the objective
of a regression tree is to predict outcomes, and therefore it splits on predictors in a way that
minimizes out-of-sample mean squared errors across all groups. In contrast, the objective of a
causal tree is to identify heterogeneous treatment effects, and therefore it splits on predictors in a
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way that maximizes the mean squared treatment effects across all groups. Let Dpi12(xl) denote the
outcome differences between Provider 1 and Provider 2 for a group of patients with characteristics
xl, a causal tree pi solves
max 1
M
[
∑M
l=1D
pi
12(xl)
2]−αM
s.t. L= {l1, ..., lM};
li ∩ lj = ∅,∀i 6= j.
(1)
where α is the tuning parameter that controls the complexity of the tree.
To estimate Dpi12, we note that each patient can only be treated by one provider, so we cannot
observe outcomes of both providers for a specific patient. Let Tij ∈ {0,1} indicate whether patient
i was treated by provider j ∈ {1,2}. Let Yij indicate the outcome of patient i at provider j. For
patients who are treated by Provider 1, we observe Yi1 but not Yi2. Similarly, for patients who are
treated by Provider 2, we observe Yi2 but not Yi1. Therefore, D
pi
12 cannot be calculated by taking
the differences of two potential outcomes for each patient. Instead, we estimate it using propensity
score matching. Let P (Xi) denote the propensity that patient i with characteristics Xi will be
treated at Provider 1 and 1 − P (Xi) represent his/her propensity of being treated by Provider
2. Then, we can estimate provider outcome difference Dpi12(xl) using inverse probability weighting
(Horvitz and Thompson, 1952),
D12(xl) =
∑
i∈l,Ti1=1 Yi1/P (Xi)∑
i∈l,Ti1=1 1/P (Xi)
−
∑
i∈l,Ti2=1 Yi2/(1−P (Xi))∑
i∈l,Ti2=1 1/(1−P (Xi))
Similar to the regression tree method, the parameter α can be chosen through cross validation
and the prediction accuracy can be evaluated using a goodness-of-fit measure on a testing set:
1
N
∑N
i=1(D
test
12 (Xi)− Dˆtest12 (Xi))2, where Dtest12 (Xi) denotes the true difference between Provider 1
and Provider 2 for patient i in the test set, and Dˆtest12 (Xi) denotes the predicted outcome difference
between the two providers for patients i in the test set. However, in contrast with a regression
tree, where the outcome Y testi of a patient i in the test set is directly observable, the true outcome
difference Dtest12 (Xi) cannot be observed. Therefore, one cannot calculate the mean squared errors
in the test set directly.
To address this issue, Su et al. (2009) proposed an “honest” approach to construct unbiased
estimates of mean squared errors using one sample to build the tree and an independent sample to
estimate treatment effects. Let Strain, Sest and Stest denote training, estimation and testing samples
respectively. Given any value of α, we first use the training sample to choose a tree structure that
solves the maximization problem in (1). Given the tree structure, we then use the estimation sample
to estimate the outcome difference between providers for patient i, i.e., Dest12 (xi). We therefore use
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Dest12 (xi) from the estimation sample as our predicted difference for the training sample. The mean
squared error to be minimized can be rewritten as
MSE(Stest, Sest) =
1
N
∑
i∈Stest
(Dtest12 (Xi)−Dest12 (Xi))2
The expected MSE is the expectation of MSE(Stest, Sest) over the test and estimation samples. By
exploiting the equality E(Dtest12 (Xi)) = E(D
est
12 (Xi)) = D
pi
12(Xi) and observing that E(D
test
12 (Xi)
2)
does not depend on the estimator, we have
EMSE(Stest, Sest) = EStest,SestMSE(S
test, Sest)
= −EStest [Dpi12(Xi)2] +EStest,Sest [V ar(Dest12 (Xi))]
In the second item, V ar(Dest12 (Xi)) is the variance of estimated differences for the corresponding
group (see Appendix A). The expected variance EStest,Sest [V ar(D
est
12 (Xi))] can be calculated as a
weighted average of the group variances, where the weights are the fractions of observations (of
the estimation sample) in the groups.
We can estimate the first term using the square of the estimated means in the training sample,
Dtrain12 (Xi)
2, minus an estimate of its variance
EˆStest [D
pi
12(Xi)
2] =Dtrain12 (Xi)
2−V ar(Dtrain12 (Xi))
We thus have the expected MSE expressed as (see Appendix B),
EMSE(Stest, Sest) =−Dtrain12 (Xi)2 +V ar(Dtrain12 (Xi)) +EStest,Sest [V ar(Dest12 (Xi))]
Note that this estimate for EMSE is based on a given α. We can now vary the value of α to
minimize expected mean squared error.
3.3.2. Causal Tree with Multiple Providers While it is straightforward to apply the
causal tree method to analyze heterogeneous provider effects for two providers, we need to clear sev-
eral hurdles to extend the method to multiple providers. Recall that the causal tree splits on predic-
tors in a way that maximizes the mean squared treatment/provider effect (i.e., 1
M
[
∑M
l=1D
pi
12(xl)
2]).
When there are multiple providers, it is unclear which provider or set of providers should be
considered as the treatment group and which as the control group. That is, eventually, we must
partition providers, as well as patient groups. Note that the partitions of providers can be different
for different patient groups and vice versa.
There are several competing alternatives for addressing this issue. Some of these require pre-
defined provider groups, while others involve modifications of the objective function of the causal
tree to accommodate differences of all pairs of providers. For instance, the causal tree method
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can be applied directly if a provider itself is considered as a group and all the other providers
are considered as another group. We can build the causal tree using patient characteristics and
a provider indicator as predictors. If the tree splits on the provider indicator, it indicates that
the provider differs from the other providers as a group. We can estimate outcome difference
between the provider and the other providers using the procedures discussed earlier. This approach
may work well when the number of providers is relatively small and providers are of similar size.
However, when the number of providers under comparison is large, the propensity of a patient to
visit a single provider will be very small, while the propensity of patients visiting all the other
providers will be very large, which makes the scenario unsuitable for propensity score matching
(Crump et al., 2008). Even if there is no issue with matching, the derived outcome information can
be confusing, because the baseline group changes as we move to compare another provider with its
peers. As a results, a patient can not directly compare the outcomes of two providers when his/her
choices of providers are limited.
An alternative is to modify the objective function. For instance, one can partition patients into
groups such that, within each group, there is a large outcome variation across all providers. Then
the objective function needs to be modified to 1
M
[
∑M
l=1
∑
i 6=jD
pi
ij(xl)
2], where Dpiij(xl) captures the
outcome difference between any pair of providers for patient group xl. The major problem of
this approach is that the groups differentiating one pair of providers may be different from those
differentiating another pair of providers. Consider a simple example where Provider 1 is better than
Provider 2 only for young patients and Provider 3 is better than Provider 4 only for male patients.
The causal tree with above modified objective function is not suitable because it will result in a
universal partition that is homogeneous across all provider pairs, and hence is not sensitive to the
heterogeneous differences across provider pairs.
A solution to these issues is to apply the causal tree method to each pair of providers. While the
approach is methodologically sound, it poses significant interpretation difficulties. For example, a
patient considering 10 providers would have to examine 45 pairwise comparisons, which is likely
to lead to confusion. To avoid this, we develop a two-stage approach. In the first stage, we analyze
pairwise provider differences. In the second stage, we condense the results into a form that enables a
patient to make direct comparisons between any provider and the state average. First, we estimate
the outcome difference between a provider j and any of the other providers. To do this, we build
N − 1 causal trees using provider j and the other N − 1 providers one at a time. From these trees,
we can estimate the outcome differences between providers j and k for patient i, Djk(Xi),∀j 6= k.
Second, we use the estimated results to derive patient-centric outcome information based on the
outcome difference between each provider and the state average. To formalize this, we let DΠj,SA(Xi)
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denote the difference between provider j and the state average of H providers from a set of causal
trees Π,
DΠj,SA(Xi) = E[Yj(Xi)− 1H (Y1(Xi) +Y2(Xi) + ...+YH(Xi))]
= 1
H
∑
k 6=jE[Yj(Xi)−Yk(Xi))]
= 1
H
∑
k 6=jD
pi
jk(Xi)
Because we partition patients into groups based on the outcome differences between two
providers, the groups we identify by comparing providers j and k may be different from those
identified by comparing providers j and l. For example, if provider j is better than provider k
at treating male patients but better than provider l at treating white patients, the causal trees
will partition patients into {male, female} when comparing providers j and k and {white, non-
white} when comparing providers j and l. However, as we will show later, this does not affect our
estimation of outcome differences between provider j and the state average.
Because propensity score is defined as the probability of a patient being treated by one provider
as opposed to another, a patient may have different propensity scores when we compare the same
provider with different alternatives. Let Pj(Xi), Pk(Xi), Pl(Xi) denote the unconditional probabili-
ties of patient i going to providers j, k and l respectively. Let Pjk(Xi) = Pr(Tij = 1|Xi, Tij+Tik = 1)
denote the probability of patient i being treated by provider j given that he/she is treated at
either j or k. Assuming the probability of being treated by a given provider can be modeled using
a multinomial logit model, then we have
Pjk(Xi) = Pj(Xi)/(Pj(Xi) +Pk(Xi))
Pjl(Xi) = Pj(Xi)/(Pj(Xi) +Pl(Xi))
These equations hold as a result of the Independence of Irrelevant Alternatives (IIA) property. Let
ljk denote the terminal node that includes patient i in a causal tree built for providers j and k.
For a given matrix of propensity scores, P (X), the proposed estimator of D
∏
j,SA(Xi) is
D
∏
j,SA(Xi|P (X)) = 1H
∑
k 6=jD
pi
jk(Xi)
= 1
H
∑
k 6=j(
∑
i∈ljk,Tij=1 Yij/Pjk(Xi)∑
i∈ljk,Tij=1 1/Pjk(Xi)
−
∑
i∈ljk,Tik=1 Yik/(1−Pjk(Xi))∑
i∈ljk,Tik=1 1/(1−Pjk(Xi))
)
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It is straightforward to see that E[Dj,SA(Xi)|P (X)] = 1H
∑
k 6=jE[Yj(Xi) − Yk(Xi)] =
D
∏
j,SA(Xi|P (X)). We can estimate the variance of DSj,SA(Xi|P (X)) as follows
V ar[D
∏
j,SA(Xi|P (X))] = V ar[ 1H
∑
k 6=j(
∑
i∈ljk,Tij=1 Yij/Pjk(Xi)∑
i∈ljk,Tij=1 1/Pjk(Xi)
−
∑
i∈ljk,Tik=1 Yik/(1−Pjk(Xi))∑
i∈ljk,Tik=1 1/(1−Pjk(Xi))
)]
= 1
H2
(
∑
k 6=j V ar[D
pi
jk(Xi|P (X))]
+
∑
k 6=j
∑
l 6=j Cov[
∑
i∈ljk,Tij=1 Yij/Pjk(Xi)∑
i∈ljk,Tij=1 1/Pjk(Xi)
,
∑
i∈ljl,Tij=1 Yij/Pjl(Xi)∑
i∈ljl,Tij=1 1/Pjl(Xi)
)
= 1
H2
(
∑
k 6=j V ar[D
pi
jk(Xi|P (X))]
+
∑
k 6=j
∑
l 6=j
Cov[
∑
i∈ljk,Tij=1 Yij/Pjk(Xi),
∑
i∈ljl,Tij=1 Yij/Pjl(Xi)]∑
i∈ljk,Tij=1 1/Pjk(Xi)
∑
i∈ljl,Tij=1 1/Pjl(Xi)
= 1
H2
(
∑
k 6=j V ar[D
pi
jk(Xi|P (X))]
+
∑
k 6=j
∑
l 6=j
∑
i∈ljk,i∈ljl V ar(Yij)∑
i∈ljk,Tij=1 1/Pjk(Xi)
∑
i∈ljl,Tij=1 1/Pjl(Xi)
Similar to what we did for two providers, we can use the law of iterated expectations and the
total law of variance to estimate the mean and variance of Dj,SA(Xi). A provider is statistically
significantly better (or worse) than the state average if the t-statistic of Dj,SA(Xi) is smaller (or
larger) than the critical values.
Before concluding, we note that the causal tree method is superior to a multivariate regression
model for our study, because the regression model assumes that the effects are linearly additive and
unobservable errors follow a certain distribution (e.g., normal distribution for linear regression and
probit models, and logistic distribution for the logit model). Hence, multivariate regression is not
suitable for studying heterogeneous (i.e., nonlinear) effects with multiple patient characteristics,
because the number of parameters becomes very large once we include the full set of interaction
effects. For example, when there are 10 patient characteristics and 35 providers, a total of 210 ×
(35−1) = 34,816 parameters are required. Methods such as LASSO can reduce the dimensionality,
but they still rely on the assumptions of linear additivity, sparsity and distribution of the errors.
In contrast, the causal tree method is a non-parametric approach, which makes no assumption on
the errors and allows the predictors to interact in a more flexible and sophisticated manner.
4. Empirical Setting and Data
We choose cardiovascular diseases (commonly known as heart diseases) as the empirical setting
for personalized health care outcome analysis for several reasons. First, cardiovascular diseases are
the leading cause of death worldwide (WHO, 2011). Each year, about 17.5 million people die from
cardiovascular diseases, which accounts for 1 in every 4 deaths, and this number is expected to grow
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to more than 23.6 million by 2030.5 Second, cardiovascular surgeries are relatively complicated
procedures. They require sophisticated skills, advanced technology and intensive post-surgical care,
which makes them candidates for sizable variations across providers (hospitals or surgeons). Third,
cardiovascular surgeries include several different types of procedures, each requiring a different set
of skills and technology. As a result, a hospital may perform well for some procedures but not as
well for others.
Cardiovascular diseases refer to (a) conditions when the blood vessels are narrowed or blocked,
which can lead to heart attack, (b) chest pain or stroke and (c) conditions that affect the heart’s
muscles, valves or rhythm. Cardiovascular surgeries are operations performed by surgeons on the
heart and blood vessels to repair the damage caused by diseases or disorders of the cardiovascular
system. In this study, we focus specifically on three cardiac surgeries — Mitral Valve Replacement
(MVR), Aortic Valve Replacement (AVR) and Coronary Artery Bypass Grafting (CABG), and
three vascular surgeries — Abdominal Aortic Aneurysm (AAA) repair, Carotid endarterectomy
(CE) and Lower Extremity bypass Graft (LEG).
4.1. Data Description and Preparation
Our study makes use of data from New York state that consist of patient-level records of all in-
and out-patient discharges from all hospitals in New York from 2008-2012. The data contain de-
tailed clinical and resource use information, including admission status (e.g., elective, emergent
and urgent), patient demographics and comorbidities, hospital identifiers, and principal and sec-
ondary diagnoses. For each discharge, the data indicate the type of surgery a patient underwent.
They also record whether a patient experienced any complications or died during the procedure or
post-surgery hospitalization. Finally, we identify readmissions by linking inpatient and outpatient
data.
We identify discharges related to the six cardiovascular procedures under this study by using
related clinical codes in the International Classification of Disease (9th revision). From 2008-2012,
a total of 124,895 patients with cardiovascular diseases were discharged from 144 hospitals. Because
some of the hospitals did not perform cardiovascular surgeries every year or have a low volume, we
focus on the 41 cardiac hospitals compared by the New York State of Health for Cardiovascular
Surgery Quality Report Cards. However, six of these hospitals did not perform vascular surgeries,
so we focus on the other 35 hospitals that perform all the six cardiovascular surgeries discussed
earlier. This results in a total of 107,252 discharges over the five year period. We focus on isolated
surgeries and exclude patients who underwent multiple types of surgeries (6,950 of the sample).
This allows us to characterize patient outcomes at each hospital for each surgery type. In addition,
5 https://www.heart.org/idc/groups/ahamah-public
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we exclude patients with missing information such as admission status. The final sample contains
a total of 99,378 discharges.
4.2. Outcome Measures and Feature Space
To measure a hospital’s outcome quality, we consider the rates of complication, readmission and
mortality as potential metrics. We identify complications using the diagnosis codes provided in the
data and focus on hospital acquired conditions rather than pre-existing conditions. We are able
to separate the two types of complications because the data indicate whether each diagnosis was
present at admission. We focus on 23 cardiovascular surgery related complications6 and use them
collectively as an outcome measure (STS, 2016, Tuinen et al., 2005, Williams et al., 1965).
In our sample, 29.58% patients had at least one of the 23 complications, while 10.55% had two
or more complications. Because a sizeable number of patients had more than one complications,
we cannot simply use a binary variable to indicate whether a patient experienced at least one
complication. The 23 complications have different severity levels. For example, complications such
as pulmonary embolism or insufficiency are relatively easy to cure, while complications such as
coma and multi-organ failure are likely to lead to patient deaths (Glance et al., 2007, Reddy et al.,
2013). Therefore, we cannot simply count the number of complications a patient experienced. To
capture both the number and the severity of complications associated with a patient during the
surgery and hospital stay, we need to translate complications into a numeric score that weights
each complication by its severity.
The Elixhauser comorbidity index is a vector of 30 binary variables in which each 1 represents
the existence of a comorbidity (Elixhauser et al., 1998). To describe the overall sickness of a patient
and to weight the severity of individual comorbidities, van Walraven et al. (2009) modified the
Elixhauser comorbidity index into a single numeric score (called “Elixhauser comorbidity score”)
by using a backward stepwise multivariate logistic regression to determine the correlation between
each comorbidity and in-hospital mortality. The parameter estimates of the regression model were
modified into a vector of weights based on methods described by Sullivan et al. (2004). The Elix-
hauser comorbidity score is calculated as the dot product of the index vector and the vector of
weights. We follow the same approach to develop a complication score as an outcome measure for
the purpose of this study. The complications and their weights are summarized in Appendix C.
The average complication score for each procedure in our study ranges from 0.11 (for CE) to 1.65
(for AAA) and the average across all procedures is 0.68 (Table 2).
6 The complications are stroke, aortic dissection, renal failure, ventilation, multi-organ failure, coma, cardiac arrest,
sepsis, gastrointestinal events, tracheal reintubation, surgical complications, tamponade, wound infection, renal dial-
ysis, mediastinum, reoperation for bleeding, pneumonia, pulmonary embolism, heart block, myocardial infarction,
pulmonary insufficiency, surgical E codes and other cardiac complications.
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To analyze readmission rate, we merge outpatient discharge data with inpatient discharge data
using the link provided by the Agency for Healthcare Research and Quality. We focus on 30-day
readmission by identifying patients who visited the same or other hospitals within 30 days after
discharge. The last month of the data is censored because their re-admissions are not observed. The
average readmission rate for each procedure ranges from 10.3% (for CE) to 18.1% (for LBG) and
that for all procedures equals 14.7%. Lastly, we observe directly from the data whether a patient
died during hospitalization. The average mortality rate for each procedure ranges from 0.3% (for
CE) to 4.7% (for MVR) and the average across all procedures is 1.7%.
Table 2 Summary of Outcomes for Different Procedures
Surgical Procedure Complication Score Readmission Rate Mortality Rate
name count mean s.d. mean s.d. mean s.d.
CE 14,539 0.11 0.77 10.3% 30.4% 0.3% 5.8%
CABG 46,098 0.66 1.80 14.0% 34.7% 1.2% 10.9%
LBG 12,227 0.41 1.47 18.1% 38.5% 1.5% 12.2%
AAA 1,356 1.65 2.86 11.6% 32.1% 2.7% 16.3%
AVR 20,061 0.99 2.30 16.4% 37.0% 2.9% 16.7%
MVR 5,097 1.47 2.80 17.0% 37.6% 4.7% 21.3%
Total 99,378 0.68 1.90 14.7% 35.4% 1.7% 12.9%
The features we use to construct the causal trees include six cardiovascular procedures (CE,
CABG, LBG, AAA, AVR and MVR), patient genders, races (white, black, hispanic, asian, native
and others), admission statuses (emergent, urgent and elective), six age groups (below 50, 50-60,
60-70, 70-80, 80-90 and above 90) and five major comorbidities (chronic heart failure, chronic lung
disease, diabetes, hypertension and renal failure) of cardiovascular diseases (STS, 2016). Consid-
ering all these features results in a total of 6 procedures × 2 genders × 6 races × 3 admissions ×
6 ages × 25 comorbidities = 41,472 different combinations of patient characteristics.
5. Results and Discussion
To address the first three key questions we raised in the Introduction, we first provide evidence
of heterogeneous outcome differences between hospitals using an exploratory approach in which
patient groups are defined a priori (for example, by procedure type, age group or comorbidity). Then
we apply the regression and causal tree methods to systematically partition patients and discuss
why the causal tree method is better able to detect the outcome differences between hospitals.
Finally, we extend the causal tree method to compare multiple hospitals and identify hospitals
that are statistically significantly better than the state average for each patient.
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5.1. Evidence of Heterogeneous Outcome Differences
To evaluate the extent to which outcome differences between hospitals are indeed heterogenous
across groups of patients, we partition patients into groups according to patient characteristics
(e.g., procedure, age and comorbidities) and use t-tests to see whether one hospital is significantly
different from another for each group. Table 3 summarizes the results for two hospitals of similar
size in New York when patients are partitioned by procedure type, age group and/or comorbidities.
The first partition compares the hospital outcomes for the procedures CE, AVR and CABG.
This shows that Hospital 1 has a lower complication score for CE (0.05 lower, p-value< 0.1), but
a higher complication score for both AVR (0.40 higher, p-value< 0.01) and CABG (0.40 higher, p-
value< 0.01). The results suggest that the outcome differences between providers are heterogeneous
across procedures.
Note, however, that the numbers in the first partition in Table 3 are simple averages for different
patient groups and are not risk adjusted. To make sure the observed heterogeneity is not an artifact
of different patient mixes, we examine some finer partitions based on patient age and comorbidities.
The second partition in Table 3 compares the same procedures but focuses on patients in their
70s. This shows that the differences between the two hospitals are still significant for AVR and
CABG. However, Hospital 1 has a lower complication score than Hospital 2 for AVR patients in
their 70s. The difference between the two hospitals is insignificant for CE. This insignificance can
be due in part to the reduction of the sample size. For both AVR and CABG, the magnitudes of
the differences between the two hospitals are larger for patients in their 70s than for patients of all
ages.
The third partition in Table 3 focuses on CE and patients of different ages (i.e., 60s, 70s and
80s). This shows that Hospital 1 has a higher complication score for patients in their 60s but has
a lower complication score for patients in their 80s. The difference between the two hospitals for
patients in their 70s is not statistically significant. These results indicate that outcome differences
are heterogeneous across patient age groups.
The fourth partition in Table 3 focuses on CE and different comorbidities (i.e., diabetes, lung
disease or heart failure). This shows that Hospital 1 has a lower complication score for patients
with diabetes but a higher complication score for patients with lung disease. The difference is
not significant for patients with hypertension. These results suggest that outcome differences are
heterogeneous across patient comorbidities.
To summarize, Table 3 suggests that outcome differences between Hospital 1 and 2 are hetero-
geneous across procedure types, patient age and comorbidities, which speaks to the first question
raised in the Introduction. It also illustrates the tradeoff between precision and power. As we see
from the fifth partition in Table 3, fine partitions pose the risk of small sample sizes that are
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inadequate for statistical testing. Of course, these partitions are for illustration purpose only and
there are many other ways to partition patients for outcome comparison. In the subsequent section,
we employ tree-based methods to obtain the optimal partition to detect heterogeneous outcome
differences between providers.
Table 3 Complication Scores at Two Hospitals for Various Patient Groups
Partition Procedure Age Group/ Hospital 1 Hospital 2 Difference in Average
Alternatives Type Comorbidity count mean s.e. count mean s.e. Complication Score
CE all 489 0.07 0.02 481 0.12 0.03 −0.05∗
1 AVR all 200 0.83 0.16 385 0.43 0.08 0.40 ∗ ∗∗
CABG all 891 0.40 0.05 969 0.23 0.03 0.17 ∗ ∗∗
CE 70 147 0.05 0.03 158 0.06 0.03 −0.02
2 AVR 70 46 0.07 0.07 97 0.53 0.17 −0.46 ∗ ∗∗
CABG 70 307 0.33 0.08 327 0.15 0.04 0.18 ∗ ∗
CE 60 58 0.12 0.08 47 0 0 0.12∗
3 CE 70 147 0.05 0.03 158 0.06 0.03 −0.02
CE 80 209 0.06 0.03 196 0.14 0.05 −0.09∗
CE diabetes 158 0.08 0.04 197 0.17 0.06 −0.10∗
4 CE lung disease 101 0.17 0.06 197 0.06 0.03 0.11∗
CE heart failure 19 0.53 0.29 29 0.28 0.24 0.25
CE 60/diabetes 49 0.41 0.17 66 0.18 0.12 0.23
5 CE 60/lung disease 29 0.17 0.14 30 0.1 0.1 0.07
CE 60/heart failure 3 1.00 1.00 6 0.50 0.50 0.50
*** p < 0.01, ** p <0.05, * p < 0.1
5.2. Comparison of Causal and Regression Trees With Two Providers
To address the second key question of how to identify patient groups that exhibit significant
outcome differences, we make use of the statistical methods we presented earlier.
We start with the traditional regression tree method using patient characteristics and a hospital
indictor (Hospital 1) as predictors. From Figure 1, we see that the regression tree splits first on
hypertension, which indicates that hypertension is the most important factor affecting outcomes.
For patients with hypertension, it splits on CE only. But for patients without hypertension, it splits
on AAA, chronic heart failure and CE. At the bottom of the tree, there are seven terminal nodes
representing seven distinct groups of patients. The numbers in a terminal node indicate the average
complication score, the total number and the fraction of patients in the node. Finally, we note that
the regression tree does not split on Hospital 1, which indicates that the choice of Hospital 1 over
Hospital 2 is not an important determinant of outcomes for any of the patient groups.
Next we apply the causal tree method to the same patients treated at these two hospitals. Our
objective is to detect significant differences in complication scores between Hospital 1 and Hospital
2. From Figure 2, we see that the causal tree splits first on CABG, which indicates that CABG is the
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Figure 1 Regression Tree Approach
most important factor differentiating outcomes at the two hospitals. For CABG patients, the tree
splits on emergent admission and hypertension, but for patients undergoing other types of surgery,
the tree does not split at all. This non-splitting is unlikely to be due to a small sample, because
the node (non-CABG) includes 61%, or 1560 patients. At the four terminal nodes, a positive value
indicates that Hospital 1 has a higher complication score and a negative value indicates otherwise.
Compared with the regression tree, the causal tree is smaller and partitions patients in a markedly
different way.
Finally, we compare the two trees to analyze which splitting method allows us to detect heteroge-
nous outcomes differences between the two hospitals. From each tree, we first identify patients from
the two hospitals at a terminal node and calculate the average complication scores. We then use
t-tests to determine wether the two hospitals have statistically significantly different complication
scores for the group of patients at the terminal node.
Table 4 shows that the regression tree partitions patients into groups of sizes ranging from 8 (the
5th node) to 2,012 (the 2nd node). Within each terminal node, the average outcome of Hospital 1
is close to that of Hospital 2 and, as a result, the differences for all seven groups are small (from
-0.13 to 0.30). More importantly, the differences are not statistically significant for six of the seven
groups at conventional significance levels.
Table 4 shows that the causal tree partitions patients into groups of sizes ranging from 153 (the
3rd node) to 2,092 (the 1st node). Within each terminal node of the causal tree, the average outcome
of Hospital 1 is very different from that of Hospital 2. The outcome differences of the four groups
range from -0.36 to 2.24 and three of the four differences are significant at conventional levels.
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Figure 2 Causal Tree Approach
As expected, the causal tree partitions patients in a way that maximizes the outcome differences
between hospitals for groups of patients, whereas the regression tree partitions patients in a way
that minimizes the outcome differences among patients.
To obtain additional insight into the differences between causal and regression trees, we compare
groups of patients at the two hospitals after the trees’ initial splitting. The regression tree begins by
partitioning patients into those with and without hypertension. The complication scores are 0.48
and 1.3 for patients with and without hypertension, respectively, so the difference is -0.82. For those
with hypertension, the complication scores are 0.4 and 0.57 for Hospitals 1 and 2, respectively, so
the difference is -0.17. For those without hypertension, the complication scores are 1.33 and 1.21 for
Hospitals 1 and 2, respectively, so the difference is 0.12. Comparing magnitudes of these differences,
we see that hypertension is important in predicting patient outcomes but not as important in
predicting outcome differences between hospitals.
In contrast, the causal tree splits first on the procedure of CABG. The complication scores
are 0.75 and 0.59 for CABG and non-CABG patients, respectively, so the difference is 0.16. For
CABG patients, the complication scores are 0.86 and 0.63 at Hospitals 1 and 2, respectively, so
the difference is 0.23. For those undergoing other types of surgeries, the complication scores are
0.50 and 0.86 at Hospitals 1 and 2, respectively, so the difference is -0.36. Comparing magnitudes
of these differences, we see that CABG is important in predicting outcome differences between
hospitals, but is not as important in predicting patient outcomes. Since our goal is to identify
provider differences that matter to patients, the causal tree is more useful to our purpose.
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Table 4 Comparison of Causal Tree And Regression Tree
Node Index of Hospital 1 Hospital 2 Difference in Average
Respective Trees count mean s.e. count mean s.e. Complication Score
1 390 1.29 0.15 271 1.11 0.16 0.18
2 1,264 0.53 0.04 748 0.66 0.07 −0.13∗
Regression 3 79 0.00 0.00 18 0.00 0.00 0.00
Tree 4 466 0.04 0.02 126 0.02 0.02 0.01
5 5 0.80 0.80 3 1.00 1.00 −0.20
6 11 5.55 1.78 8 5.25 1.47 0.30
7 23 4.65 1.00 5 4.60 3.03 0.05
1 1,560 0.50 0.05 532 0.86 0.10 −0.36 ∗ ∗∗
Causal 2 109 0.88 0.17 327 0.56 0.09 0.32 ∗ ∗
Tree 3 32 3.16 0.87 121 0.92 0.20 2.24 ∗ ∗∗
4 537 0.72 0.08 199 0.59 0.14 0.13
*** p < 0.01, ** p <0.05, * p < 0.1
5.3. Causal Tree for Multiple Providers
As described in Section 3, to identify hospitals that are statistically significantly different from the
state average for certain patient groups, we first construct causal trees for each pair of hospitals,
which requires a total of 35× 34/2 = 595 trees. For each patient, we estimate the differences in
complication score between a hospital and the state average, and calculate the standard error of
the difference using the approach of Section 3. Table 5 summarizes the results for an example of
six different patients. The best hospital for each patient is highlighted in bold. We observe that,
while some hospitals (e.g., hospitals 3 and 4) are uniformly better than the state average for all six
patients, others (e.g., hospital 26) are uniformly worse. However, for hospitals that are uniformly
better (or worse) than the state average, the magnitude of the differences varies for individual
patients. For example, Hospital 3 is better than the state average by 0.74 for the 2nd patient
(AVR, 80s, one comorbidity) and by 0.19 for the 3rd patient (CE, 70s, two comorbidities). There
are also hospitals that are better than the state average for some patients but worse for others.
For example, Hospital 1 is better for the 3rd (CE, 70s, two comorbidities) and 5th (MVR, 30s,
two comorbidities) patients but worse for the 2nd(AVR, 80s, 1 comorbidity), 4th (CABG, 40s, one
comorbidity) and 6th (AAA, 60s, two comorbidities) patients. These results indicate that outcome
differences between pairs of hospitals are indeed heterogenous across patients, and that different
patients have different sets of hospitals that are significantly better that the state average.
Of course, Table 5 only shows six patients as examples. We have analyzed the outcome differences
across hospitals for all of the patients this study. To provide an overall visual illustration of the
heterogeneity in outcomes across hospitals for different patients, we group patients by procedure
type, age group and comorbidities.7 For each patient group, we use Yijk ∈ {−1,0,1} to indicate
7 We tried different ways to group patients and noticed that, when patients are grouped by procedure type, comor-
bidities and age group, the resulting heat map has obvious patterns. Patients within each group may have different
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Table 5 Comparison of Complication Score with the State Average for Different Patients
Hospital LBG, 70s AVR, 80s CE, 70s CABG, 40s MVR, 30s AAA, 60s
Index 1 Comorb 1 Comorb 2 Comorb 1 Comorb 2 Comorb 2 Comorb
(1) (2) (3) (4) (5) (6)
1 −0.37+++ −0.59+++ −0.32+++ −0.35+++ −0.62+++ −0.39+++
2 −0.25+++ −0.74+++ −0.19+++ −0.24+++ −0.48+++ −0.28+++
3 −0.20+++ −0.44+++ −0.35+++ −0.25+++ −0.23++ −0.21+++
4 −0.17++ −0.43+++ −0.41+++ −0.17++ −0.17+ −0.24+++
5 −0.25+ −0.65+++ −0.05 −0.09 −0.05 −0.10
6 −0.04 −0.53+++ −0.16++ −0.03 −0.13 0.02
7 −0.04 −0.23 −0.07 0.02 −0.17 −0.04
8 −0.17++ −0.04 −0.12++ −0.07 0.13 −0.15++
9 0.05 −0.19++ −0.29+++ 0.06 0.07 −0.07
10 −0.11 −0.30+++ −0.01 −0.10+ −0.10 −0.12
11 −0.05 −0.17 −0.17 −0.08 −0.10 −0.16++
12 0.00 −0.14 −0.26++ −0.01 −0.06 0.00
13 −0.19+++ −0.16 −0.34++ −0.22+++ −0.28+++ −0.32+++
14 0.01 −0.06 −0.16 −0.16+++ −0.26+++ −0.22+
15 −0.05 0.08 0.05 0.07 0.00 0.04
16 0.00 −0.10 −0.05 −0.05 −0.15+ −0.06
17 0.07 0.25 −0.04 −0.10++ −0.08 0.06
18 −0.15+ 0.04 −0.03 0.02 −0.23++ −0.07
19 0.02 0.04 −0.26++ −0.08++ 0.03 −0.10
20 0.01 0.13 0.08 −0.10++ 0.21- −0.13+
21 0.13- 0.07 0.07 −0.10+ 0.06 0.11
22 0.06 0.19 −0.11 0.06 0.15 0.05
23 0.38 0.84- 0.37 0.18 0.13 0.18
24 0.09 0.03 −0.07 0.03 −0.03 −0.01
25 0.14- −0.26+ 0.30- 0.04 0.12 −0.02
26 0.16- 0.14 0.15 −0.03 0.13 0.27-
27 −0.15++ 0.42- 0.34− −0.07+ 0.11 −0.11
28 0.04 0.12 0.44− 0.00 0.40- 0.03
29 0.11 0.24- 1.25- −0.10+ −0.03 0.29-
30 0.28- 0.10 −0.06 0.25- 0.49- 0.28-
31 0.29- 0.34- 0.02 0.15- 0.11 0.13-
32 0.05 0.31- −0.22+ 0.21- −0.15+ 0.30-
33 0.04 0.52- 0.34− 0.16- 0.11 0.18-
34 0.26- 0.55- 0.17- 0.67- 0.48- 0.46-
35 0.05 0.63- 0.20 0.46- 0.57- 0.37-
+++, ++, +: better than state average at 99%, 95% and 90% confidence level
---, --, -: worse than state average at 99%, 95% and 90% confidence level
whether hospital j is statistically significantly worse than, the same as, or better than the state
average at a 10% significance level for patient i in group k. Then we calculate the overall per-
formance of hospital j for patient group k using Y¯jk =
1
Njk
∑Njk
i=1 Yijk and present the results in a
heat map (Figure 3), where the yellow/red colors indicate that a hospital’s overall performance
is better/worse than the state average, and the intensity of the colors indicates the fraction of
patients in a cell for which a hospital is better/worse than the state average.
sets of hospitals that are significantly better than the state average. However, as shown in the heat map, a majority
of patients in each group have the same best set of hospitals.
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From Figure 3, we observe that many of the cells in the middle (i.e., those associated with
hospitals 11-25) are orange, which indicates that these hospitals are not significantly different from
the state average for many patient groups. The majority of the cells in rows at the top (e.g., those
associated with hospitals 1-3) have the color of yellow, indicating that these hospitals are better
than the state average for most patient groups. In contrast, the red color of the cells in rows at the
bottom (e.g., those associated with hospitals 34-35) indicates that these hospitals are worse than
the state average for most patient groups. Rows near the top having colors of yellow and orange
indicate that the corresponding hospitals are better for some patient groups, but are not statistically
different from the state average for other patient groups. Likewise, rows near the bottom with a
mixture of red and orange cells indicate that these hospitals are worse for some patient groups
but are not significantly different from the state average for other groups. Interestingly, there are
hospitals (e.g., 13 and 27) that are significantly better than the state average for some patient
groups (e.g., patients with hypertension) but are significantly worse than the state average for
other patient groups (e.g., patients at 60s with no major comorbidities).
Figure 3 Comparison of Hospital Complication Scores for Patient Groups
Note: Patients are grouped by age group (i.e., 50s to 90s), comorbidity and surgery. Acronyms for comorbidities:
HTN - hypertension, DM - diabetes, CHF - chronic heart failure, NA - no comorbidities. Acronyms for surgeries:
CE - carotid endarterectomy, LBG - lower extremity bypass graft, MVR - mitral valve repair, AVR - aortic valve
repair, CABG - coronary artery bypass grafting.
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5.4. Outcome Differences Based on Other Metrics
We have also performed similar analyses of the heterogeneity in outcome differences using in-
hospital mortality and 30-day readmission as metrics. The results are displayed in the heat maps
of Figures 8 and 9 in Appendices D and E. We see that, because mortality is a rare event for the
procedures in this study, most hospitals are not statistically significantly different from the state
average, as indicated by the prevalence of orange in Figure 8. However, we observe that Hospitals
2, 3 and 30 are better than the state average for many patient groups and that Hospitals 22, 26
and 33 are worse for some patient groups and not significantly different from the state average for
other patient groups.
Readmission is a more common event than mortality, so using readmission rate as the outcome
metric allows us to identify more hospitals that are significantly different from the state average.
From Figure 9, we see that Hospitals 3, 27, 9 and 10 are better than the state average for most
patient groups, whereas Hospitals 6, 23, 31 and 34 are worse than the state average for most patient
groups. Most other hospitals (e.g., Hospitals 1, 2, 5 and 8) are either not statistically different from
or are better than the state average, depending on the patient group. Similar to the case with
complication score as the outcome metric, we see that some hospitals (e.g., Hospitals 17, 19, 26
and 30) are better than the state average for some patient groups but worse than the state average
for other patient groups.
Using either complication score or readmission rate allows us to identify a relatively large set of
hospitals that are significantly different from the state average. However, for a given patient group,
the best hospitals that are significantly better than the state average with respect to complication
score may be different than those with respect to readmission rate. For example, for patient group
CE50HTN (CE, 50s, with hypertension), Hospitals 1, 2, 4, 8 and 13 are significantly better than
the state average when outcomes are measured by complication score, but Hospitals 3, 9, 17 and 27
are significantly better than the state average when outcomes are measured by readmission rate.
Likewise, for a given hospital, the set of patient groups for which it produces the best outcomes
are different when different outcome metrics are used. For example, Hospital 2 is significantly
better than the state average for all patient groups when outcomes are measured by complication
score but for only patient group CE90CHF (CE, 90s, with chronic heart failure) when outcomes
are measured by readmission rate. The reason is that these metrics measure different capabilities.
Readmission rate measures the ability of a hospital to ensure patients are healthy (or at least
stable) when released. In contrast, complication rate measures the ability of a hospital to avoid
problems such as hospital-acquired infections, while the patient is in the hospital. Prior studies
that have found mixed results regarding the correlation between readmission and complication
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rates (see for example Hospital Compare,8 2016, Lawson et al., 2013, Merkov et al., 2015, Robbins,
2013) are consistent with the differences we have observed.
6. Managerial Implications
We now turn to the last of our four key questions, which is what are the benefits of patient-centric
information to patients, payers and providers. To evaluate the impacts on patients, we compare
the sets of best hospitals and potential outcomes under population-average and patient-centric
information. To illustrate the potential benefit to payers, we use the Hospital Acquired Condition
Reduction Program as an example of how patient-centric information enables payers to better align
payment with hospital performance. To illustrate the benefits to providers, we discuss how patient-
centric information can help hospitals better align their strategic focus with their strengthes and
focus their process improvement efforts where they will have the greatest impact.
6.1. Implications for Patients
Existing hospital rating systems, such as those of US News and the LeapFrog Group, and quality
report cards, such as the New York Cardiac Surgery Quality Report Cards, compare hospitals using
O/E ratios of observed to expected metrics (e.g., mortality rate). The expected rates are population
averages estimated from a multivariate logit/probit model that includes patient demographics and
comorbdities to control for patient severity of illness and hospital dummies to capture the fixed
effects of individual hospitals. US News aggregates ratings into broad categories such as heart
surgery and cancer, rather than reporting them for individual procedures such as mitral valve or
aortic valve surgeries. As a result, it captures only the average effect of a hospital for all discharged
patients. The LeapFrog Group and NY quality report cards report ratings for individual procedures
such as CABG, mitral valve, aortic valve surgeries, so they capture the average effect of a hospital
for a procedure. But they still make use of population-average O/E ratios that do not capture the
heterogeneity of outcome differences across groups of patients undergoing the same procedure.
Because population-average based rankings, including those making use of O/E ratios, assume
away heterogeneity in provider performance across patient groups, they suggest that the same
hospitals (or surgeons or physicians) are best for all patients. This leads to two problems. First,
as we discussed in the previous section, some hospitals that are high performers on average have
average or below average outcomes for some patient groups. So, O/E ratios will guide some patients
to suboptimal choices of providers. Second, because they suggest a “one size fits all” picture of
hospital quality, population-average based rankings encourage patients to concentrate unnecessarily
in a small subset of hospitals. The resulting capacity overloads will lead to longer patient wait
times that could negatively impact patient outcomes.
8 https://www.medicare.gov/hospitalcompare/compare.html
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6.1.1. Comparison of Best Hospitals To illustrate the difference between patient-centric
and population-average information in terms of their ability to guide patients to the best hospi-
tals, we focus on complication score as the outcome metric.9 We use each type of information to
identify the best hospital(s) (i.e., those that achieve the minimum complication score) for each pa-
tient group. Finally, we compute the weighted average complication score across all patients. The
difference between the average complication score under patient-centric and population-average
information is a measure of the expected incremental value of patient-centric information to a
randomly selected patient who chooses the best hospital for him/her based on the available infor-
mation.
Because the dependent variable (complication score) is left truncated at zero, we use a tobit model
instead of a logit/probit model to identify the best hospital under population-average information.
For all models, we have robust standard errors clustered by hospital to allow for differences in the
variance/standard errors due to arbitrary intra-group correlation (KC and Terwiesch, 2011, Jaeker
and Tucker, 2015). The hospital with the smallest O/E ratio is designated as the best hospital
for all patient groups. To rank hospitals using patient-centric information, we use the causal tree
method discussed earlier. As we noted earlier, this method can identify different hospitals as best
for different patient groups. Furthermore, if the outcome differences between hospitals are not
significant, the tree may not differentiate between them. As a result, multiple hospitals may be
identified as best for a given patient group.
Applying these methods to data for NY patients discharged in 2012 after one of the six car-
diovascular surgeries listed earlier generates the results in Table 6. These identify the set of best
hospitals and the number of patients for whom each hospital is best under population-average
and patient-centric information. The difference in hospital rankings, and the patient complication
scores they produce, that occur when we switch from population-average information to patient-
centric information, characterize the value of patient-centric information to an individual patient
who seeks out the best hospital for him/her using the available information. In addition to guiding
patients to hospitals that will reduce their expected complication score, patient-centric information
guides patients to a wider range of hospitals, which will be more feasible from a capacity standpoint
to provide patients with the best available treatment.
9 We use complication score because it captures a wide range of negative patient outcomes and shows substantial
variation across hospitals. But the difference between patient-centric and population average information can be
evaluated in terms of any of the outcome metrics we introduced earlier, or a composite score that combines them,
without changing the overall conclusions about the value of patient-centric information.
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6.1.2. Comparison of Patient Outcomes There are two main insights from Table 6. The
first is that the hospital that is best on average across the entire population is not best for most
patients. Patient-centric information reveals that different hospitals are best for different patients.
For most of the surgical procedures, the top-ranked hospital under population-average information
is the top hospital only for a minority of patients. For CE, the top-ranked hospital under population-
average information is only best for 36 out of 2681 patients. For CABG, it is optimal for 30 out of
7953 patients. For AAA, it is optimal for 4 out of 185 patients. For AVR, it is optimal for 9 out of
4025 patients. For MVR, it is optimal for 13 out of 1054 patients. And for LBG, the top-ranked
hospital under population-average information is not the best hospital for any group of patients.
The second insight from Table 6 is that choosing the best hospital on the basis of patient-
centric, rather than population-average, information results in a significant reduction in average
complication score. This reduction ranges from 0.11 to 0.40, which is equivalent to a 4.5% to 16%
reduction in mortality, across the six cardiac specialties. The average reduction across all patients
is 0.21, which is equivalent to a 8.8% reduction in mortality.
To get a better sense of which patient groups benefit most from patient-centric information, we
group patients by procedure type, age group and major comorbidities (as what we did for the earlier
heat maps). The average reduction of complication score for each patient group is summarized in
Figure 4. Generally speaking, patients with diabetes or chronic heart failure benefit more than
those with other (or no) comorbidities from patient-centric information. Among all the patient
groups, LBG patients with diabetes or chronic heart failure benefit the most and MVR patients
with chronic heart failure or no comorbidities benefit the least.
Figure 5 displays the distribution of percentage reduction in complication score. From this his-
togram, we see that around 97.5% of patients achieve a positive reduction in their complication
score under patient-centric information. Only a small fraction of patients are equally well off under
population-average and patient-centric information.
6.1.3. Other Outcome Metrics As noted earlier, we can make use of patient-centric in-
formation to rank hospitals according to other outcome metrics besides complication score. To
illustrate how hospitals perform differently on other metrics, Table 7 compares hospitals based
on complication score, readmission and mortality rates for two patients. As we did in the heat
maps earlier, we identify hospitals that are statistically significantly better than the state average.
Table 7 shows that the set of above average hospitals changes when different outcome metrics are
used. Hospitals 3 and 4 are significantly better than the state average for Patient 1 with respect to
complication score but are not different from the state average with respect to readmission rate. In
this example, there are hospitals that are significantly better than the state average with respect
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Table 6 Impact on Average Patient Complication Score From Using Patient-Centric Instead of
Population-Average Information in Hospital Selection
Population-Average Patient-Centric Avg. Reduction
Information Information of Complication
Score
hospital index 2 1 2 4 5 11
CE number of patients 2681 2049 36 97 472 27
change in complication score -0.10 0 -0.20 -0.12 -0.17 -0.11
hospital index 3 1 2 4 5 3
CABG number of patients 7953 5573 4 12 2334 30
change in complication score -0.20 -0.13 -0.03 -0.20 0 -0.19
hospital index 12 1 2 4 5 3
LBG number of patients 2366 1810 494 12 42 8
change in complication score -0.40 -0.41 -0.18 -0.48 -0.20 -0.40
hospital index 2 1 2 4 5 12
AAA number of patients 185 138 4 1 39 3
change in complication score -0.12 0 -0.05 -0.12 -0.06 -0.12
hospital index 3 1 2 4 5 3
AVR number of patients 4025 2499 1139 29 349 9
change in complication score -0.25 -0.23 -0.06 -0.25 0 -0.24
hospital index 3 1 2 3 5
MVR number of patients 1054 658 14 13 359
change in complication score -0.11 -0.13 0 -0.15 -0.12
Figure 4 Complication Reduction by Patient Groups
Note: Patients are grouped by age group (i.e., 50s to 90s), comorbidity and surgery. Acronyms for comorbidities:
HTN - hypertension, DM - diabetes, CHF - chronic heart failure, NA - no comorbidities. Acronyms for surgeries:
CE - carotid endarterectomy, LBG - lower extremity bypass graft, MVR - mitral valve repair, AVR - aortic valve
repair, CABG - coronary artery bypass grafting.
to all three outcome metrics used (e.g., Hospital 33 for Patient 1 and Hospital 15 for Patient 2).
However, it may be the case that no hospital is above average for all metrics for a given patient. If
this is the case, then a patient with his/her primary care physician must either evaluate the multi-
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Figure 5 Complication Reduction Under Patient-Centric Information
dimensional outcomes subjectively or place weights on the various outcome metrics and perform a
quantitative ranking based on the composite metric.
A sensible approach for a ranking service like LeapFrog or US News would be to create a website
that allows a patient to enter his/her characteristics and medical condition, along with weights on
outcome metric, and then use the methodology of this paper to generate a personalized ranking of
providers (Huckman and Kelly, 2013).
6.2. Implications for Hospitals and Payers
Payers are increasingly seeking ways to tie hospital reimbursement to performance. For example, the
Hospital Acquired Condition Reduction Program (HACRP) was established in 2013 as a response
to increasing costs of complications. This program penalizes low-performing hospitals with regard
to the Patient Safety Indicator (PSI) 90 Composite Index Value (Domain 1) and five infection
measures (Domain 2).10 For each measure, CMS uses two years of historical data to calculate risk-
adjusted infection rates and then ranks hospitals accordingly. Each hospital is assigned a score
between 1 and 10 for each measure based on its relative rank in deciles for that measure. There
is only one score for Domain 1. A hospital’s Domain 2 score is calculated as the average of the
domain’s individual measures. The total score is calculated as the weighted average of Domain 1
and Domain 2 scores, where the weights are 15% and 85% for the two domains. In 2015, CMS
10 The PSI measures include rates of pressure ulcer, iatrogenic pneumothorax, central venous catheter-related blood-
stream infection, postoperative hip fracture, perioperative pulmonary embolism or deep vein thrombosis, postopera-
tive sesis, postoperative wound dehiscence and accidental puncture or laceration. The five infection measures are rates
of central line-associated bloodstream infection, catheter-associated urinary tract infection, colon and hysterectomy
surgical site infection, methicillin-resistant staphlococcus aureus bacteremia, and clostrium dfficile infection.
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Table 7 Outcome Metrics for Individual Patients
Hospital Patient 1 (LBG, 70s, 1 Comorb) Patient 2 (AVR, 80s, 1 Comorb)
Index Complication Readmission Mortality Complication Readmission Mortality
1 −0.37+++ −0.03- 0.00- −0.59+++ −0.01- −0.02+++
2 −0.25+++ 0.04- −0.01+++ −0.74+++ 0.01- −0.02+
3 −0.20+++ −0.09+++ −0.01+++ −0.44+++ −0.11+++ −0.02+
4 −0.17++ −0.05+++ 0.00- −0.43+++ −0.02- 0.00-
5 −0.25+ −0.01- 0.01- −0.65+++ −0.01- −0.02+++
6 −0.04- 0.13-- −0.01- −0.53+++ 0.29-- −0.02+++
7 −0.04- −0.03+ 0.00- −0.23- −0.03- 0.01-
8 −0.17++ 0.02- 0.00- −0.04- 0.04- 0.00-
9 0.05- −0.06+++ 0.00- −0.19++ −0.10+++ −0.01-
10 −0.11- −0.05++ 0.00- −0.30+++ −0.04+ −0.01-
11 −0.05- 0.00- −0.01+ −0.17- −0.02- 0.01-
12 0.00- 0.07-- 0.01- −0.14- 0.12-- 0.02-
13 −0.19+++ −0.03++ 0.00- −0.16- −0.04- −0.01-
14 0.01- −0.04++ −0.01+ −0.06- −0.07- −0.01-
15 −0.05- −0.06++ 0.00- 0.08- −0.02- 0.00-
16 0.00- −0.01- 0.02- −0.10- 0.01- 0.00-
17 0.07- 0.05- 0.00- 0.25- 0.11-- 0.01-
18 −0.15+ −0.02- −0.01- 0.04- −0.05++ 0.00-
19 0.02- −0.03+ 0.00- 0.04- −0.03++ 0.00-
20 0.01- −0.04++ 0.01- 0.13- −0.07+++ 0.00-
21 0.13- −0.02- 0.01- 0.07- −0.05+++ 0.00-
22 0.06- −0.02- 0.00- 0.19- −0.03- 0.02-
23 0.38- 0.18-- 0.01- 0.84- 0.12-- 0.03-
24 0.09- 0.00- 0.02- 0.03- 0.00- 0.02-
25 0.14- −0.03+ 0.00- −0.26+ −0.04++ −0.03+++
26 0.16- 0.01- 0.01- 0.14- −0.06+++ 0.02-
27 −0.15++ −0.08+++ −0.01- 0.42-- −0.10+++ 0.01-
28 0.04- 0.02- 0.01- 0.12- −0.09+++ 0.01-
29 0.11- −0.03- 0.00- 0.24- −0.07+++ 0.00-
30 0.28-- −0.07+++ −0.01- 0.10- −0.08+++ −0.03++
31 0.29-- 0.14-- 0.00- 0.34-- 0.33-- −0.01-
32 0.05- 0.02- 0.00- 0.31-- −0.01- 0.01-
33 0.04- 0.01- 0.00- 0.52-- 0.02- 0.00-
34 0.26-- 0.11-- 0.00- 0.55-- 0.13-- 0.02-
35 0.05- −0.01- −0.01- 0.63-- −0.01- 0.00-
+++, ++, +: better than state average at 99%, 95% and 90% confidence level
---, --, -: worse than state average at 99%, 95% and 90% confidence level
reduced total payments (i.e., across all patients) by 1% for hospitals that ranked among the worst
quartile with regard to hospital acquired infections.
6.2.1. Impact of Patient-Centric Information on Hospital Payments The Hospital
Acquired Condition Reduction Program is based on population-average outcome information and so
does not recognize heterogenous outcome differences across patient groups. Consequently, applying
a uniform penalty to these hospitals does not recognize their acceptable or even high performance
for some patient groups. Similarly, hospitals that are not penalized under the HACRP may perform
poorly for some patient groups. In addition to misaligning penalties with performance, an incentive
system based on population-average information can hide areas of poor performance and discourage
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hospitals from addressing them. In contrast, patient-centric information allows payers to assess
hospital performance by patient group and better align payments with quality to provide shaper
incentives for quality improvement.
To illustrate a HACRP-type program under patient-centric information, we group patients by
procedure type, age group and comorbidities. For each patient group, we use Yijk ∈ {0,1} to indicate
whether hospital j is among the worst quartile for patient i in group k. We then calculate the overall
performance of hospital j for patient group k using Y¯jk =
1
Njk
∑Njk
i=1 Yijk and display the results in
the heat map of Figure 6. We see that only Hospitals 23 and 35 are among the worst quartile
across all patient groups. Hospitals 31, 33 and 34 are among the worst quartile for a majority of
patient groups, but they have areas (e.g., procedure CE for Hospital 31) that are not among the
worst quartile. Likewise, Hospitals 20 and 21 are not among the worst quartile for the majority of
patient groups, but they have areas (e.g., old CE patients with chronic heart failure for Hospital
20) that are among the worst quartile.
Payments would be better aligned with performance if hospitals were penalized for only their
low-performing areas. To see how, in Figure 7, we compare scenarios in which hospitals are pe-
nalized based on population-average and patient-centric information. Under population-average
information, there are eight hospitals with average performance among the worst quartile, each of
which would be penalized by 1% on all payments. The other hospitals are not penalized at all. In
contrast, under patient-centric information, only two hospitals are not penalized at all. The rest
are penalized on some portion of their payments. Hence, more hospitals would have a financial
incentive to improve under patient-centric than under population-average information.
6.2.2. Impact on Hospital Strategy and Improvement Efforts Payments based on
patient-centric information provide more focused incentives for hospitals to improve quality, be-
cause they reward hospitals for incremental improvements. For example, consider a hospital that
discharges 1,000 patients a year, of which 100 are CABG patients. The infection rate across all
patients is 1%, but is 5% for CABG patients. If, under the current HACRP, the hospital is not
penalized, then it has no economic incentive to improve. Even if it is being penalized, it may be
the case that reducing infections among CABG patients will not have a large enough effect on the
overall infection rate to eliminate the penalty. However, if HACRP penalties were based on patient-
centric information, and therefore individually penalized payments for CABG patients, then the
hospital would have economic incentives to reduce the CABG patient infection rate, regardless of
whether payments for other types of patients were being penalized or not.
Beyond its use in targeted incentives, transparent patient-centric outcome information can help
hospitals learn from one another. For example, the heat map in Figure 3 shows that Hospital 13 has
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Figure 6 Comparison of Hospitals’ Performance for Patient Groups
Note: Patients are grouped by age group (i.e., 50s to 90s), comorbidity and surgery. Acronyms for comorbidities:
HTN - hypertension, DM - diabetes, CHF - chronic heart failure, NA - no comorbidities. Acronyms for surgeries:
CE - carotid endarterectomy, LBG - lower extremity bypass graft, MVR - mitral valve repair, AVR - aortic valve
repair, CABG - coronary artery bypass grafting.
Figure 7 Percentage Payment under Patient-Centric and Population-Average Measure
very low complication rates for hypertension patients, despite having average performance for other
patients. This may indicate that Hospital 13 has made some kind of innovation that enables them
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to better protect these patients. Hence, patient-centric information in Figure 3 can help hospitals
spot best practices that might be shared to elevate performance across the industry.11
Finally, in addition to supporting incentives for hospitals to improve outcomes for specific patient
groups, patient-centric information may also incent hospitals to focus on the patients they are able
to treat most successfully. For example, suppose a hospital has exceptionally good outcomes (e.g.,
low complication scores), relative to the state average, for elderly patients, but poor outcomes for
younger patients. The penalties from an HACRP-type program would make the younger patients
less economically attractive to the hospital. And, if patient-centric information were transparently
available to patients, demand from younger patients would presumably be weaker as well. Both
factors would encourage the hospital to focus on elderly patients, in its process design and marketing
efforts. Other hospitals might be incented to focus on particular medical procedures or patient
groups (e.g., patients with hypertension, diabetes or cancer). Over time, this would encourage a
network of providers that leverage their individual strengths to produce better patient outcomes.
7. Conclusion
In recent years, there have been many wide-ranging efforts to improve the delivery of health care
in the United States. Perhaps the most straightforward of these has been the push for better
and more transparent outcome information to help patients find the best available care for them.
Unfortunately, as we have shown, the standard approach of computing risk-adjusted outcomes
produces population averages that do not accurately represent the likely outcomes for all patients.
In this paper, we have shown that the relative performance of hospitals is heterogeneous across
patient groups. Consequently, patient-centric rankings of hospitals are significantly different than
rankings based on population-average information.
In this study, we have addressed the challenges of generating patient-centric outcome information
and hospital ranking. Using six cardiovascular surgeries as the clinical setting, we studied the out-
comes of thirty-five hospitals in NY based on different metrics. We extended the causal tree method
for multiple hospitals to recursively partition patients into groups that exhibit significant outcome
differences between hospitals. We quantified the outcome differences for groups of patients using
propensity score matching and derived patient-centric estimates of outcome differences between
hospitals for individual patients. Our analysis shows that outcome differences between hospitals
are heterogeneous not only across procedure types, but also along other dimensions such as patient
age and comorbidities.
11 Competition may hinder sharing of best practices across hospitals. But there are platforms for such sharing. For
example, the Quality Collaborative of the Michigan Society of Thoracic Surgeons http://mstcvs.org/qc.html has been
set up precisely to encourage the open heart programs in the state of Michigan to share data and practices.
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We compared the best hospitals based on population-average and patient-centric information. We
found that, for the majority of patients (around 97.5%), the best hospitals are different than those
indicated as best by a population-average rating. Furthermore, we found that patient-centric infor-
mation results in a larger set of best hospitals, which suggests more opportunities for distributing
patient workload across hospitals to reduce patient waiting time. Most importantly, we compared
the potential outcomes when patients are treated at the best hospitals based on the two types of
information, and estimated that the complication score could be reduced by 46% (equivalent to
a 8.8% reduction in mortality) by using patient-centric information instead of population-average
information.
In addition to the manifest benefits to patients, patient-centric information offers potential ben-
efits to hospitals and payers as well. Using the Hospital Acquired Infection Reduction Program as
an example, we showed that patient-centric information allows the CMS to better align payments
(and penalties) with patient outcomes. This in turn provides sharper incentives for hospitals to
improve quality. Finally, the more detailed patient-centric information can help hospitals to un-
derstand their strengths and weaknesses, as well as those of their peers. This can help them better
align their strategies with their strengths, and also to learn from one another.
Lastly, providers may select patients they are most skilled at treating, and patients may select
providers from whom they are likely to receive the best outcome. This will create an attenuation
bias and will make it more difficult to detect differences among providers. In other words, our
approach tend to generate a conservative estimate of outcome differences, which means that the
impact of using patient-centric information may be even larger than our analysis indicates. It may
be possible to combine the tree method with causal inference methods, and we leave this for future
research.
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Appendix A: Estimation of the Variance of Outcome Difference Estimator
We assume that outcomes of patients treated by the same provider are i.i.d. and outcomes of patients treated
by Providers 1 and 2 are independent. From sample S, we have
V ar[DS12(Xi)|P (X)] =
∑
i∈l,Ti1=1 1/P
2(Xi)
(
∑
i∈l,Ti1=1 1/P (Xi))
2V ar(Yi1)
+
∑
i∈l,Ti2=1 1/P
2(Xi)
(
∑
i∈l,Ti2=1 1/P (Xi))
2V ar(Yi2)
By the low of total variance, we have
V ar[DS12(Xi)] =EP (X)[V ar(D
S
12(Xi)|P (X))] +V ar[Ei∈l(DSjk(Xi)|P (X))]
Appendix B: Estimation of Mean Squared Errors
The expected MSE is the expectation of MSE(Stest, Sest) over test and estimation samples
EMSE = EStest,SestMSE(S
test, Sest)
= EStest,Sest [(D
test
12 (Xi)−Dest12 (Xi))2]
= EStest,Sest [(D
test
12 (Xi)−Dpi12(Xi))2 +Dest12 (Xi)2−Dpi12(Xi)2 + 2Dtest12 (Xi)(Dpi12(Xi)−Dest12 (Xi))]
= EStest,Sest [(D
test
12 (Xi)−Dpi12(Xi))2 +Dest12 (Xi)2−Dpi12(Xi)2 + 2Dpi12(Xi)(Dpi12(Xi)−Dest12 (Xi))]
= EStest,Sest [(D
test
12 (Xi)−Dpi12(Xi))2 + (Dest12 (Xi)−Dpi12(Xi))2]
= EStest [(D
test
12 (Xi)
2− 2Dtest12 (Xi)Dpi12(Xi) +Dpi12(Xi)2]pi +EStest,Sest [(Dest12 (Xi)−Dpi12(Xi))2]
= EStest [D
test
12 (Xi)
2−Dpi12(Xi)2] +EStest,Sest [V ar(Dest12 (Xi))]
where we exploit the equality E(Dtest12 (Xi)) = E(D
est
12 (Xi)) =D
pi
12(Xi). Because E(D
test
12 (Xi)
2) does not de-
pend on the estimator,12 minimizing above EMSE is equivalent to minimizing
EMSE(Stest, Sest) =−EStest [Dpi12(Xi)2] +EStest,Sest [V ar(Dest12 (Xi))]
12 For each observation i in the test sample, there is a true outcome difference between Providers 1 and 2, Dtest12 (Xi),
which we do not observe.
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Appendix C: Complications and Weights
Table 8 The Weights of Complications Used to Calculate Complication Score
Complication Coefficient Std.Err. Weight
Stroke 1.03 ∗ ∗∗ 0.12 2
AorticDissection 3.16 ∗ ∗∗ 0.33 7
RenalFailure 1.46 ∗ ∗∗ 0.05 3
Ventilation 0.85 ∗ ∗∗ 0.07 2
MultiOrganFailure 2.16 ∗ ∗∗ 0.07 5
Coma 2.76 ∗ ∗∗ 0.25 6
CardiacArrest 1.79 ∗ ∗∗ 0.09 4
Sepsis 1.03 ∗ ∗∗ 0.14 2
GIEvent 0.44 ∗ ∗∗ 0.10 1
TrachealReintubation 1.22 ∗ ∗∗ 0.06 3
SurgComp 1.11 ∗ ∗∗ 0.15 2
Tamponade 1.02 ∗ ∗∗ 0.14 2
PulmonaryInsuff 0.46 ∗ ∗∗ 0.06 1
Constant −4.93 ∗ ∗∗ 0.04
Note: Robust standard errors are clustered by hospital.
The outcome variable is death during hospitalization. Complications
dropped from backward stepwise multivariate logistic regression include
wound infection, renal dialysis, mediastinum, reoperation for bleeding,
pneumonia, pulmonary embolism, heart block, myocardial infarction,
surgical E codes and other cardiac complications.
*** p < 0.01, ** p <0.05, * p < 0.1
Wang, Li and Hopp: Patient-centric Information
Article submitted to Management Science; manuscript no. 43
Appendix D: Mortality and Readmission for Groups of Patients
Figure 8 Comparison of Hospitals’ Mortality for Groups of Patients
Note: Patients are grouped by age group (i.e., 50s to 90s), comorbidity and surgery. Acronyms for comorbidities: HTN - hyper-
tension, DM - diabetes, CHF - chronic heart failure, NA - no comorbidities. Acronyms for surgeries: CE - carotid endarterectomy,
LBG - lower extremity bypass graft, MVR - mitral valve repair, AVR - aortic valve repair, CABG - coronary artery bypass
grafting.
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Figure 9 Comparison of Hospitals’ Readmission for Groups of Patients
Note: Patients are grouped by age group (i.e., 50s to 90s), comorbidity and surgery. Acronyms for comorbidities: HTN - hyper-
tension, DM - diabetes, CHF - chronic heart failure, NA - no comorbidities. Acronyms for surgeries: CE - carotid endarterectomy,
LBG - lower extremity bypass graft, MVR - mitral valve repair, AVR - aortic valve repair, CABG - coronary artery bypass
grafting.
